Actively Recruiting
Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries
Led by Cairo University · Updated on 2024-08-20
46
Participants Needed
2
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to compare the effectiveness of ketofol for the prevention of emergence delirium in pediatric patients undergoing squint surgery, in comparison to dexmedetomidine.
CONDITIONS
Official Title
Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patients aged 2 to 6 years
- Both sexes
- ASA physical status I and II
- Scheduled for squint surgery
You will not qualify if you...
- Refusal of parents
- Sensitivity to any study medication
- Known neurological disease affecting postoperative emergence delirium assessment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Abu Elresh Hospitals ( Cairo university )
Cairo, Egypt
Actively Recruiting
2
Abu ElResh hospital
Cairo, Egypt
Not Yet Recruiting
Research Team
M
Muhammad Kh Ibrahim
CONTACT
M
Mohamed El Abdelfatah
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here